This course will address current treatments for specific tumour groups and future challenges for developping services in different health care settings.
It will focus on delivering evidence-based clinical practice and achieving quality assured outcomes for patients undergoing abdominal and pelvic cytoreductive surgery and intraperitoneal chemotherapy.